15
total announcements
544220.BO · 15 min delayed
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd submitted a statement under Regulation 32 of SEBI (LODR) Regulations, 2015, disclosing that the IPO proceeds of INR 578.30 lakhs were fully utilized for the disclosed purposes, with no deviation or variation in the utilization of funds.
Clinitech Laboratory Ltd
The Board of Directors of Clinitech Laboratory Ltd approved the unaudited standalone and consolidated financial results for the half year ended September 30, 2026, along with a limited review report. The company also considered the utilization of IPO proceeds and noted the internal audit report for the same period.
Clinitech Laboratory Ltd
The Board of Directors of Clinitech Laboratory Ltd approved the Un-Audited Standalone & Consolidated Financial Result for the half year ended September 30, 2026, along with a Limited Review Report. The Board also noted the utilization of IPO proceeds and the Internal Audit report for the same period.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 to consider and approve the Un-Audited Standalone & Consolidated Financial Result of the Company along with Limited Review Report (LRR) for the half year ended September 30, 2026.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has submitted a certificate stating that Related Party Transactions (RPT) under Regulation 23 of SEBI (LODR) Regulations, 2015 are not applicable to the company for the half year ended on September 30, 2026, as it is listed under the SME portal of BSE Limited and does not exceed the threshold limit.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that the regulation is not applicable to the company as all its shares are in demat form and no requests for rematerialisation were received during the quarter ended September 30, 2026.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has announced the closure of its trading window for insiders from October 1, 2026, to allow for the consideration and approval of unaudited standalone and consolidated financial results for the half year ended September 30, 2026. The trading window will reopen 48 hours after the declaration of the financial results.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has announced the voting results and scrutinizer's report for its 16th Annual General Meeting (AGM) held on September 24, 2026. All resolutions were approved by the members of the company. The resolutions included the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the re-appointment of a director.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd held its 16th Annual General Meeting on September 24, 2026, through video conferencing. The meeting was attended by 8 shareholders, including 4 promoter and promoter group shareholders and 4 public shareholders. The company adopted its standalone and consolidated audited financial statements for the financial year ended March 31, 2026, and re-appointed a director liable to retire by rotation.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has published a newspaper advertisement regarding the notice and e-voting for its 16th Annual General Meeting scheduled to be held on September 24, 2026, through video conferencing.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has announced its Annual General Meeting (AGM) to be held on September 24, 2026, through video conferencing. The company's register of members and share transfer books will be closed from September 18 to 24, 2026. The AGM will include the annual report, notice of AGM, board's report, and financial statements.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has announced the book closure dates for its 16th Annual General Meeting (AGM) to be held on September 24, 2026. The book closure dates are from September 18, 2026 to September 24, 2026.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has released its annual report for FY 2025-26, highlighting its operational and financial performance, expansion plans, and governance initiatives.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd's Board of Directors approved the appointment of a director retiring by rotation, the Board's report for FY 2025-26, and other matters at its meeting held on August 17, 2026.
Clinitech Laboratory Ltd
Clinitech Laboratory Ltd has scheduled a board meeting on August 17, 2026, to consider and approve various matters, including the appointment of a director, the board's report for FY 2025-26, and the 16th Annual General Meeting.